KD Logo

Nuvectis Pharma Inc [NVCT] Shares Fall Approximately -36.00% Over the Year

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nuvectis Pharma Inc shares valued at $9,980 were purchased by Poradosu Enrique on Nov 19 ’24. At $4.99 per share, Poradosu Enrique acquired 2,000 shares. The insider’s holdings grew to 1,506,319 shares worth approximately $7.95 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, BENTSUR RON purchased 20,000 shares, netting a total of over 98,400 in proceeds. Following the buying of shares at $4.92 each, the insider now holds 3,266,424 shares.

Before that, Carson Michael J. had sold 2,755 shares from its account. In a trade valued at $22,478, the Vice President, Finance traded Nuvectis Pharma Inc shares for $8.16 each. Upon closing the transaction, the insider’s holdings decreased to 2,755 shares, worth approximately $0.46 million.

As published in their initiating research note from Ladenburg Thalmann on July 13, 2022, Nuvectis Pharma Inc [NVCT] has been a Buy and the price target has been revised to $21.

Analyzing NVCT Stock Performance

During the last five days, there has been a surge of approximately 4.14%. Over the course of the year, Nuvectis Pharma Inc shares have dropped approximately -36.69%. Shares of the company reached a 52-week high of $12.10 on 03/14/24 and a 52-week low of $4.61 on 11/22/24. A 50-day SMA is recorded $6.89, while a 200-day SMA reached $7.12. Nevertheless, trading volume fell to 69551.0 shares from 75100.0 shares the previous day.

Support And Resistance Levels for Nuvectis Pharma Inc (NVCT)

According to the 24-hour chart, there is a support level at 5.08, which, if violated, would cause prices to drop to 4.87. In the upper region, resistance lies at 5.42. The next price resistance is at 5.55. RSI (Relative Strength Index) is 39.55 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.63, which suggests the price will decrease in the coming days. Percent R is at 90.69%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular